Eastgate Biotech Corp (ETBI)

Currency in USD
0.0040
0.0000(0.00%)
Closed·
ETBI Scorecard
Full Analysis
Stock has taken a big hit over the last week
ETBI is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.00400.0040
52 wk Range
0.00010.0045
Key Statistics
Prev. Close
-
Open
0.004
Day's Range
0.004-0.004
52 wk Range
0.0001-0.0045
Volume
-
Average Volume (3m)
28.98K
1-Year Change
3,900%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ETBI Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Eastgate Biotech Corp Company Profile

Eastgate Biotech Corp., a development stage company, develops novel formulations of natural compounds and pharmaceutical products. The company is developing pharmaceutical products, such as Lorazepam oral spray for acute seizures emergency treatment; Ketoconazole 2% topical ointment for treatment of skin fungal infections; and Metformin chewable/ sublingual tablets for treatment of type 2 diabetes. It is also developing natural products and dietary supplements, including E-drops Nano and PURALEN that are self-nanoemulsifying compositions containing natural essential oils for oral administration; Glucora, a soft gelatin capsule with Banaba extract in self-emulsifying formulation for oral administration; URBAN POWER, a soft gelatin capsule with Ursolic acid and Banaba extract in self-emulsifying formulation for oral administration; Vitamin D3 nanoemulsion, a nanoemulsion with cholecalciferol; and Cleanezze, a hand sanitizer containing oil. Eastgate Biotech Corp. has collaboration with Biotech Corp. to develop a vaccine against COVID-19. The company was formerly known as Eastgate Acquisitions Corporation and changed its name to Eastgate Biotech Corp. in December 2014. Eastgate Biotech Corp. was founded in 1999 and is based in Toronto, Canada.

Employees
3

Compare ETBI to Peers and Sector

Metrics to compare
ETBI
Peers
Sector
Relationship
P/E Ratio
0.0x−1.4x−0.5x
PEG Ratio
0.000.010.00
Price/Book
0.0x0.7x2.6x
Price / LTM Sales
0.0x0.7x3.3x
Upside (Analyst Target)
0.0%96.0%45.1%
Fair Value Upside
Unlock13.0%7.4%Unlock

Earnings

Latest Release
Mar 04, 2019
EPS / Forecast
-- / --
Revenue / Forecast
23.14K / --
EPS Revisions
Last 90 days

ETBI Income Statement

FAQ

What Stock Exchange Does Eastgate Biotech Trade On?

Eastgate Biotech is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Eastgate Biotech?

The stock symbol for Eastgate Biotech is "ETBI."

What Is the Eastgate Biotech Market Cap?

As of today, Eastgate Biotech market cap is 1.06K.

What Is Eastgate Biotech's Earnings Per Share (TTM)?

The Eastgate Biotech EPS (TTM) is -0.01.

From a Technical Analysis Perspective, Is ETBI a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Eastgate Biotech Stock Split?

Eastgate Biotech has split 1 times.

How Many Employees Does Eastgate Biotech Have?

Eastgate Biotech has 3 employees.

What is the current trading status of Eastgate Biotech (ETBI)?

As of 04 Aug 2025, Eastgate Biotech (ETBI) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.